Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Due to recent regulatory changes from multiple to single use the new accu-chek aviva launched in the market in 2014 is not suitable for in vitro diagnostic use by healthcare professionals in a clinical setting.